Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Single-Cell RNA-Sequencing of 370 Bone Marrow and Peripheral Blood Immune Cell Samples from Patients with MGUS and Smoldering Multiple Myeloma Reveal Significant Immune Dysregulation at the MGUS Stage, and Novel Interactions between Tumor and Immune Cells

Romanos Sklavenitis-Pistofidis, Ting Wu, Mahshid Rahmat, Yoshinobu Konishi, Elizabeth D. Lightbody, Michael Timonian, Junko Tsuji, Danielle T. Firer, Nicholas J. Haradhvala, Cinnie Yentia Soekojo, Xiyue Wang, Daniel Heilpern-Mallory, François Aguet, Gad Getz, Irene Ghobrial

Blood (2022) 140 (Supplement 1): 860–861.

https://doi.org/10.1182/blood-2022-168911

Published: 2022

Journal Articles

Efficacy of Frontline Treatments for Newly Diagnosed Transplant-Ineligible Multiple Myeloma, a Network Meta-Analysis

Maggie Wong, Chen Wang, Cinnie Yentia Soekojo, Hung Chew Wong, Sanjay De Mel, Melissa Ooi, Miny Samuel, Yu Yang Soon, Wee Joo Chng

Blood (2022) 140 (Supplement 1): 4345–4346.

https://doi.org/10.1182/blood-2022-165849

Published: 2022

Journal Articles

Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Identifies a T-Cell Population That Correlates with Clinical Outcomes

Sanjay de Mel, Jonathan Adam Scolnick, Chern Han Yong, Stacy Xu, Cinnie Yentia Soekojo, Fangfang Song, Melissa Ooi, Wee Joo Chng

Blood (2022) 140 (Supplement 1): 4336–4337.

https://doi.org/10.1182/blood-2022-164465

Published: 2022

Journal Articles

Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Finds an Immune Microenvironment Gene Signature That Correlates with Clinical Outcomes

Sanjay De Mel, Jonathan Adam Scolnick, Chern Han Yong, Xiaojing Huo, Stacy Xu, Cinnie Yentia Soekojo, Fangfang Song, Melissa Ooi, Wee Joo Chng

Blood (2021) 138 (Supplement 1): 2653.

https://doi.org/10.1182/blood-2021-149107

Published: 2021

Journal Articles

Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Eunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Cinnie Yentia Soekojo, Melissa Ooi, Wee-Joo Chng, Sanjay De Mel

Blood (2021) 138 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2021-151644

Published: 2021

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Yin Jie Koh, Louis-Pierre Girard, MBChB, Hian Li Esther Hian Li Chan, MRCP, FRCPATH, Joanne Shu Xian Lee, MBBS, MRCP, Yen-Lin Chee, MBChB, FRCPath, PhD, Anand Jeyasekharan, Sanjay de Mel, MRCP(UK) FRCPath, Cinnie Yentia Soekojo, MD, Xin Liu, Liang Piu Koh, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Miny Samuel

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-138700

Published: 2020

Journal Articles

Identifying the Genomic Profile of Functional High-Risk Multiple Myeloma Patients

Cinnie Yentia Soekojo, MD, Tae-Hoon Chung, Muhammad Shaheryar Furqan, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-136553

Published: 2020

Journal Articles

Evaluation of Maintenance Therapy in Myeloma in an Asian Population

Cinnie Yentia Soekojo, MD MRCP, Sanjay De Mel, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS

Blood (2018) 132 (Supplement 1): 3231.

https://doi.org/10.1182/blood-2018-99-110624

Published: 2018

Journal Articles

Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

Cinnie Yentia Soekojo, MD MRCP, Guo-miao Wang, Yunxin Chen, Joshua Casan, Grace Wolyncewicz, Adeline Lin, LM Poon, Liang Piu Koh, Lip Kun Tan, Melissa Ooi, Yang Liu, Xiao-Jun Huang, MD, Andrew Spencer, MD, Sathish Kumar, Jin Lu, Wee Joo Chng, MB ChB, MRCP, PhD

Blood (2017) 130 (Supplement 1): 3119.

https://doi.org/10.1182/blood.V130.Suppl_1.3119.3119

Published: 2017

Journal Articles

Cytogenetic Abnormalities and Treatment with New Drugs on Clinical Trials Are Important Prognostic Markers for Myeloma in the Era of ISS and FISH Analysis

Cinnie Yentia Soekojo, Adeline Lin, Michelle Poon, Liang Piu Koh, Lip Kun Tan, Melissa G. Ooi, Wee Joo Chng, MB ChB, MRCP, PhD

Blood (2016) 128 (22): 4498.

https://doi.org/10.1182/blood.V128.22.4498.4498

Published: 2016

NARROW

Single-Cell RNA-Sequencing of 370 Bone Marrow and Peripheral Blood Immune Cell Samples from Patients with MGUS and Smoldering Multiple Myeloma Reveal Significant Immune Dysregulation at the MGUS Stage, and Novel Interactions between Tumor and Immune Cells

Efficacy of Frontline Treatments for Newly Diagnosed Transplant-Ineligible Multiple Myeloma, a Network Meta-Analysis

Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Identifies a T-Cell Population That Correlates with Clinical Outcomes

Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Finds an Immune Microenvironment Gene Signature That Correlates with Clinical Outcomes

Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Identifying the Genomic Profile of Functional High-Risk Multiple Myeloma Patients

Evaluation of Maintenance Therapy in Myeloma in an Asian Population

Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

Cytogenetic Abnormalities and Treatment with New Drugs on Clinical Trials Are Important Prognostic Markers for Myeloma in the Era of ISS and FISH Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only